lipo-c with tirzepatide Using Lipo C Injections GLP-1 Medication for Effective Weight Loss Lipo C and Tirzepatide: Safety

In contrast, since the CANVAS (Canagliflozin Cardiovascular Assessment Study) reported a higher rate of lower extremity amputations in patients with DM treated with canagliflozin, safety concerns were raised about the use of SGLT2i in patients with PAD

Glutathione suppresses tyrosinase in three ways: direct inhibition through chelation of copper, interference with the transfer of tyrosinase to premelanosomes, tyrosinase inhibition indirectly by antioxidant effect

Pesci A, Balbi B, Majori M, et al

Obexelimab in systemic lupus erythematosus with exploration of response based on gene pathway co-expression patterns: a double-blind, randomized, placebo-controlled, phase 2 trial

The use of behavioural health services decreased dramatically for patients prescribed GLP-1 drugs during the study period

Peptide Sciences, one of the largest gray-market research peptide suppliers in the US, voluntarily shut down in March 2026